Header image

Poster walk, Friday - Methodologies in Cancer Screening Evaluation

Tracks
Friday, June 20, 2025
11:15 - 12:30
Smedien, Centralvaerkstedet

Speaker(s)

Agenda Item Image
Mr Guillermo Bosch
Specialist Physician In Preventive Medicine And Public Health
Hospital Del Mar Research Institute

202 - Scoping review of observational methods for assessing breast cancer screening programs’ impact on mortality

Biography

Preventive Medicine and Public Health Specialist Physician working in the Epidemiology Department of Hospital del Mar in Barcelona, Spain. Currently undergoing my PhD studies in Breast Cancer Screening Evaluation.
Agenda Item Image
Mr Guillermo Bosch
Specialist Physician In Preventive Medicine And Public Health
Hospital Del Mar Research Institute

203 - Methodological challenges for assessing the impact of a population-based breast cancer screening program on mortality in southern Europe (ORBITA Study)

Biography

Preventive Medicine and Public Health Specialist Physician working at the cancer unitf the Department of Epidemiology of Hospital del Mar in Barcelona, Spain. Currently undergoing my PhD studies on evaluation of breast cancer screening programs.
Agenda Item Image
Dr Ondřej Májek
Scientific Lead
National Screening Centre ÚZIS ČR

192 - Linkage of healthcare data to compare mammography screening results by observed screening interval: real-world data from the Czech national programme

Biography

Dr Ondřej Májek is the Head of Department of International Affairs at the Institute of Health Information and Statistics of the Czech Republic and the scientific lead of its National Screening Centre, where he is involved in monitoring and evaluation of screening programmes and introduction of new disease early detection projects. He is also an assistant professor and the head analyst of cancer screening programmes at the Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University in Brno, Czech Republic. His research interests include monitoring and evaluation of disease detection programmes, cancer epidemiology, and medical biostatistics.
Mr Adrià Moncusí
Associate Epidemiologist at the Department of Epidemiology and Evaluation
Hospital Del Mar Research Institute

191 - Impact of COVID-19 on Tumor Diagnoses: Delays and Their Consequences

Biography

Adrià Moncusí holds a degree in Microbiology from UAB and a master's in Public Health from UPF-UAB. He is currently an associate at the Epidemiology and Evaluation Service at Hospital del Mar in Barcelona and a member of RICAPPS. He collaborates in research on breast cancer screening effectiveness . In the clinical field, he works in the Cancer Prevention and Registry Unit, coordinating early detection programs for breast and cervical cancer, and the Tumor Registry, while contributing to the Infection Prevention and Control Program. He is secretary of the Clinical Practice Adequacy Commission and coordinator of the Vaccination Committee.
Agenda Item Image
Dr Sisse Njor
Professor
Research Unit For Screening And Epidemiology, Lillebaelt Hospital, Vejle, Denmark Denmark

179 - Was it excess incidence or true overdiagnosis? Systematic review of the reported data from randomised controlled trials of screening for breast cancer with mammography

Biography

Professor Sisse Helle Njor have a master in statistics from Aarhus University and a PhD in epidemiology from University of Copenhagen, Denmark. She has been involved in cancer screening research since 2001 and is currently leading the Research unit for screening and epidemiology at University Hospital of Southern Denmark, Vejle.
Mr Casper Pedersen
Ph.d Student
Sygehus Lillebælt

176 - Estimating breast cancer screening’s impact on mortality using target trial emulation

Biography

Casper Pedersen is a PhD student specializing in epidemiology at the Research Unit for Screening and Epidemiology, Lillebaelt Hospital, Denmark. Whose research focuses on evaluating the impact of breast cancer screening programs using advanced statistical methods to inform evidence-based public health strategies. With a background in statistics, Casper Pedersen is particularly interested in addressing biases in observational studies and developing robust methodologies.
Mrs Cécile Quintin
Epidemiologist
Santé Publique France

298 - Estimated coverage rate of colorectal cancer screening in France in 2022

Biography

Cécile Quintin graduated from ENSAE (national school of statistics) and held several positions in pharmaceutical companies before working at the French public health institute (Santé publique France) since 2012. She joined the cancer team and became responsible for evaluating the national organized colorectal cancer screening programme. The main activities are the creation of the national colorectal cancer screening database, the production and analysis of performance indicators, the statistical analysis of their temporal and geographical variations, the statistical analysis of the relationship between screening and social deprivation...
Agenda Item Image
Ms Mette Kielsholm Thomsen
Postdoc
Department of Clinical Epidemiology, Aarhus University

230 - Screening specific biases are neglected in observational studies of colorectal cancer outcomes: a systematic review

Biography

Mette K. Thomsen is working with epidemiological studies of colorectal cancer screening. With a background from public health and clinical epidemiology, she has a special focus on evaluation of screening programs as well as social inequality in screening. Current position: postdoc

Chair(s)

Agenda Item Image
Beatrice Lauby-Secretan
Head, Iarc Handbooks Of Cancer Prevention
Iarc

Return to the ICSN Website here

 

 

#ICSN25

loading